IBRN Among Health Care ETFs
End-of-day Nov 13, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.4% | +1.1% | +11.3% | −13.7% | +5.8% | +18.2% | +68.4% | — | +41.2% |
| Peer average | −0.1% | +0.8% | +3.7% | +4.0% | +21.5% | +25.9% | +71.5% | +27.0% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$52 of every $1,000 in IBRN is Biogen
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | BIIBBiogen | Healthcare | 5.23% | $523.22 | 1,826 | $463K |
| 2 | NBIXNeurocrine Biosciences | Healthcare | 5.08% | $508.43 | 2,578 | $450K |
| 3 | EWTXEdgewise Therapeutics | Healthcare | 5.00% | $499.93 | 9,294 | $442K |
| 4 | ALKSAlkermes | Healthcare | 4.70% | $469.83 | 8,676 | $415K |
| 5 | PRAXPraxis Precision Medicines | Healthcare | 4.45% | $445.12 | 1,137 | $394K |
| 6 | AXGNAxogen | Healthcare | 4.39% | $439.02 | 6,622 | $388K |
| 7 | ARGXArgenx SE | Healthcare | 4.28% | $427.80 | 387 | $378K |
| 8 | PTCTPTC Therapeutics | Healthcare | 4.26% | $426.22 | 5,807 | $377K |
| 9 | SRRKScholar Rock | Healthcare | 3.82% | $381.87 | 7,247 | $338K |
| 10 | DNTHDianthus Therapeutics | Healthcare | 3.73% | $372.71 | 3,691 | $330K |
| 11 | 326030.KSSK Biopharmaceuticals | Healthcare | 3.64% | $364.22 | 4,956 | $322K |
| 12 | HLUN-B.COH. Lundbeck | Healthcare | 3.51% | $350.75 | 34K | $310K |
| 13 | DYNDyne Therapeutics | Healthcare | 3.36% | $335.63 | 16K | $297K |
| 14 | XENEXenon Pharmaceuticals | Healthcare | 3.20% | $319.77 | 6,717 | $283K |
| 15 | ACADAcadia Pharmaceuticals | Healthcare | 2.98% | $297.94 | 14K | $263K |
of the $114B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | BIIB | Biogen | 5.23% |
| 2 | NBIX | Neurocrine Biosciences | 5.08% |
| 3 | EWTX | Edgewise Therapeutics | 5.00% |
| 4 | ALKS | Alkermes | 4.70% |
| 5 | PRAX | Praxis Precision Medicines | 4.45% |
| 6 | AXGN | Axogen | 4.39% |
| 7 | ARGX | Argenx SE | 4.28% |
| 8 | PTCT | PTC Therapeutics | 4.26% |
| 9 | SRRK | Scholar Rock | 3.82% |
| 10 | DNTH | Dianthus Therapeutics | 3.73% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 16, 2025 | Dec 19, 2025 | $0.32 |
| Dec 17, 2024 | Dec 20, 2024 | $0.10 |
| Dec 20, 2023 | Dec 27, 2023 | $0.0063 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0082 |